GGrantIndex
Sort

130,381 grants matching hiv

DYNAMIC NUCLEAR POLARIZATION SOLID STATE NMR SPECTROMETER FOR BIOMOLECULAR STUDIE

$2,309,300
Ann E McDermott · New York Structural Biology Center · S10 · FY2010 · RR

IMPLEMENTATION OF AN HIV CARE AND SUPPORT PROGRAM IN SOUTH AFRICA UNDER PEPFAR

$2,309,274
Kechi Anah · Africare · U2G · FY2010 · PS

Miami Center for AIDS Research

$2,309,083
Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2020 · AI

UCLA Los Angeles Brazil AIDS Consortium

$2,307,974
Yvonne J Bryson · University Of California Los Angeles · U01 · FY2011 · AI

COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)

$2,307,858
Tom Denny · Duke University · N01 · FY2021 · AI

WOMENS INTERAGENCY HIV STUDY

$2,307,662
Georgetown University · U01 · FY2002 · AI

Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa

$2,307,055
Diane V Havlir · University Of California, San Francisco · P01 · FY2014 · HD

MULTICENTER AIDS COHORT STUDY

$2,306,709
Howard Brown Health Center · U01 · FY2004 · AI

Multi-component HIV Vaccines Using Engineered Envelopes

$2,306,242
Novartis Vaccines And Diagnostics, Inc. · P01 · FY2003 · AI

NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT

$2,305,737
David Montefiori · Duke University · N01 · FY2018 · AI

?Resetting immune homeostasis: a non-invasive approach towards HIV eradication

$2,305,584
Rafick-Pierre Sekaly · Case Western Reserve University · U01 · FY2017 · AI

IMMUNE EPITOPE AND ANALYSIS PROGRAM: Infectious Diseases

$2,305,155
Stephen Wilson · La Jolla Institute For Immunology · N01 · FY2022 · AI

NEUROAIDS: EFFECTS OF METHAMPHETAMINE AND HCV

$2,304,650
Igor Grant · University Of California, San Diego · P01 · FY2006 · DA

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$2,304,554
Andrea Perez · Indiana State Department Of Health · U62 · FY2015 · PS

Molecular Interactions Of Lymphoid Cell Receptors

$2,304,533
David H. Margulies · Niaid Extramural Activities · Z01 · FY2007 · AI

GH11-1155, Moz: TARGET: INCREASING ACCESS TO HIV COUNSELING, TESTING & ENHANCING HIV/AIDS PREVENT

$2,304,527
Dawn Dixon · Population Services International · U2G · FY2016 · GH

Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos

$2,303,826
Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2020 · HL

NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D

$2,303,260
David C Montefiori · Duke University · N01 · FY2016 · AI

Looking into the Heart of Cannabis and HIV

$2,302,500
Claudia Martinez · University Of Miami School Of Medicine · DP2 · FY2022 · DA

Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People who Inject Drugs: a Randomized Controlled Trial

$2,302,500
Hansel Emory Tookes · University Of Miami School Of Medicine · DP2 · FY2021 · DA

HIV PREVENTION TRIAL UNITS

$2,302,325
Fenway Community Health Center · U01 · FY2001 · AI

Seattle-Lausanne-Kampala CTU

$2,302,202
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2019 · AI

Fill-Finish, Release, and Stability Testing of HIV-1 gp120 Proteins

$2,302,002
Fred Mack · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI

Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-65

$2,301,135
Megan Elizabeth Patrick · University Of Michigan At Ann Arbor · R01 · FY2023 · DA

NIAID Preclinical Development Support

$2,300,627
William Coale · Advanced Bioscience Laboratories, Inc. · N01 · FY2011 · AI